BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 679835)

  • 1. [Cefamandol: pharmacokinetics with normal and impaired renal function (author's transl)].
    Höffler D; Moecke D; Sassmann M
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1334-8. PubMed ID: 679835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of intravenous Cefradin in normal and restricted renal function (author's transl)].
    Höffler D; Koeppe P
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1169-74. PubMed ID: 808712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology of cefamandole in patients with reduced renal function.
    Czerwinski AW; Pederson JA
    Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of ticarcillin in patients with normal and impaired renal function (author's transl)].
    Höffler D; Dalhoff A; Koeppe P
    Dtsch Med Wochenschr; 1978 Jun; 103(22):931-5. PubMed ID: 350535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of cefamandole in rabbits].
    Klimova VS; Bobrov VI; Nazarova OI; Skala LZ; Iakovlev VP
    Antibiotiki; 1982 Dec; 27(12):34-8. PubMed ID: 7165292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the diffusion rate of cefamandole in various human tissue (author's transl)].
    Plaue R; Müller O; Fabricius K; Bethke RO
    Arzneimittelforschung; 1978; 28(12):2343-9. PubMed ID: 582953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefapirin in patients with normal and impaired renal functions.
    Bergan T; Orjavik O; Brodwall EK
    Arzneimittelforschung; 1981; 31(10):1773-6. PubMed ID: 7198453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ceftazidime in normal and impaired renal function.
    Höffler D; Koeppe P; Williams KJ
    Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefamandole in patients undergoing hemodialysis.
    Campillo JA; Lanao JM; Dominguez-Gil A; Tabernero JM; Rubio F
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):416-20. PubMed ID: 500264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of aspoxicillin in subjects with normal and impaired renal function.
    Geyer J; Höffler D; Koeppe P
    Arzneimittelforschung; 1988 Nov; 38(11):1635-9. PubMed ID: 3214450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of pharmacokinetics.
    Cutler RE
    Rev Infect Dis; 1984; 6 Suppl 4():S803-8. PubMed ID: 6522921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.
    Haffner D; Schaefer F; Girard J; Ritz E; Mehls O
    J Clin Invest; 1994 Mar; 93(3):1163-71. PubMed ID: 8132756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concentration of cefamandole in human renal parenchyma (author's transl)].
    Kroening U; Brückner O; Nagel R
    Arzneimittelforschung; 1981; 31(11):1976-9. PubMed ID: 7198478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of moxalactam in adults].
    Humbert G; Leroy A; Fillastre JP
    Sem Hop; 1983 Jun; 59(26):1963-7. PubMed ID: 6310787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation of renal allograft weight to metabolic index ratios and glomerular filtration rate among living-unrelated kidney transplant patients: a cross-sectional study.
    Amante AJ; Piñon-Barretto SC
    Transplant Proc; 2008 Sep; 40(7):2313-8. PubMed ID: 18790222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefamandole pharmacokinetics and dosage adjustments in relation to renal function.
    Brogard JM; Kopferschmitt J; Spach MO; Grudet O; Lavillaureix J
    J Clin Pharmacol; 1979 Jul; 19(7):366-77. PubMed ID: 479381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.